CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

Earnings Estimate Revisions for CRISPR Therapeutics For the fiscal year ending December 2024, this company is expected to earn -$5.17 per share, which is a change of -166.5% from the year-ago ...

View Full Profile. Learn about our Editorial Policies. “What’s significant about this is it’s taking CRISPR to that next step of what it can be used for, and in this case, it’s correcting mutations ...

CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...